| Application no. and date | 04764411.7 (espacenet) (Federated) (European Patent Register), 20040824 | | Patent/reg. no. and date | DK/EP 1660482, 20090429 | | Publication date | 20060531 | | Priority no. and date | DE 10339862, 20030829 | | EP pub. no. and date |
EP 1660482 20060531 | | Effective date | | | Applicant/owner | Boehringer Ingelheim International GmbH, Binger Strasse 173
55216 Ingelheim am Rhein, DE | | Applicant ref. no. | 152875 | | Inventor | SCHMID, Rolf, Talstrasse 37
88487 Baltringen, DE,
Sieger, Peter, Klingenäcker 7
88441 Mittelbiberach, DE,
SOBOTTA, Rainer, Ludwig-Richter-Str. 6
55218 INGELHEIM, DE | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 31/4439 (2006.01) , A61P 7/02 (2006.01) , C07D 401/12 (2006.01) | | Title | 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-mehtyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsyre-ethylester-methansulfonat og dennes anvendelse som lægemiddel | | Int. application no. | EP2004009432 | | Int. publication no. | WO2005028468 | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
